Vol 12, No 4 (August 31, 2023): Chinese Clinical Oncology

When not having a tissue may not be an issue in advanced lung cancer

Searching for the optimal sequence of dual-targeted CAR T cells in relapsed/refractory acute lymphoblastic leukemia

Positivity of the KEYNOTE-394 but negativity of the KEYNOTE-240: differences in efficacy between Eastern and Western populations?

Utility of psychotherapy assessed with Kessler scale in a population of cancer patients undergoing systemic oncological treatment: a mono-institutional experience

Efficacy of scalp-sparing volumetric-modulated arc therapy approach in reducing scalp radiation dose for patients with glioblastoma: a cross-sectional study

Phosphotriesterase-related protein as a novel prognostic predictor for hepatocellular carcinoma patients

Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study

Next stage of collaboration in East Asia gastric cancer treatment

A review on paying for advanced cancer therapeutics: hard truths and realities in Asia

Role of radiotherapy and its contribution to immunotherapy in hepatocellular carcinoma

Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm

Treatment strategy for de novo metastatic nasopharyngeal carcinoma: a literature review

The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer

First case report of tumor lysis syndrome after third line systemic therapy with gemcitabine and pazopanib in a patient with lower extremity soft tissue sarcoma